Distribution of TAP gene polymorphisms and extended MHC haplotypes in Mexican Mestizos and in Seri Indians from northwest Mexico

Genes and Immunity

Volumn 3, Issue 2, 2002, Pages 78-85

  Balladares, S ^a   Alaez, C ^a   Pujol, J ^b   Duran, C ^b   Navarro, J L ^b   Gorodezky, C ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b State Laboratory of Public Health   (Mexico)

Author keywords

Extended MHC molecular haplotypes; TAP polymorphism; TAP DNA typing

Indexed keywords

ABC TRANSPORTER; AMINO ACID; TAP2 PROTEIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG; TAP1 PROTEIN, HUMAN; TAP2 PROTEIN, HUMAN;

ALLELE; AMERICAN INDIAN; ANTHROPOLOGY; ARTICLE; ASIAN; BRAZIL; CAUCASIAN; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MEXICO; NEGRO; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SOUTHERN EUROPE; ETHNOLOGY; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETICS;

SERI;

ATP-BINDING CASSETTE TRANSPORTERS; GENE FREQUENCY; GENES, MHC CLASS I; GENES, MHC CLASS II; HAPLOTYPES; HUMANS; INDIANS, NORTH AMERICAN; LINKAGE DISEQUILIBRIUM; MEXICO; POLYMORPHISM, GENETIC;

EID: 0036546186     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363835     Document Type: Article

References (70)

1. Heemels MT, Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Ann Rev Biochem 1995; 64: 463-491.
2. Vos JC, Spee P, Momburg F, Neefjes J. Membrane topology and dimerization of the two subunits of the transporter associated with antigen processing reveal a three-domain structure. J Immunol 1999; 163: 6679-6685.
3. Colonna M, Bresnahan M, Bahram S, Strominger JL, Spies T. Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci USA 1992; 89: 3932-3936.
4. Powis, SH, Mockridge I, Kelly A et al. Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. Proc Natl Acad Sci USA 1992; 89: 1463-1467.
5. Powis SH, Teisserenc H. TAP, LMP and HLA-DM typing protocols. In: Charron D (ed). Genetic Diversity of HLA Functional and Medical Implication Vol. 1. EDK: Paris 1997, pp 226-231.
6. Marsh SGE, Bodmer JG, Albert ED et al. Nomenclature for factors of the HLA system, 2000. Hum Immunol 2001; 62: 419-468.
7. Faucz FR, Probst CM, Petzl-Erler ML. Polymorphism of LMP2, TAP1, LMP7 and TAP2 in Brazilian Amerindians and Caucasoids: implications for the evolution of allelic and haplotypic diversity. Eur J Immunogenet 2000; 27: 5-16.
8. Momburg F, Roelse J, Howard JC, Butcher GW, Hämmerling GJ, Neefjes JJ. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 1994; 367: 648-651.
9. Neefjes JJ, Gottfried E, Roelse J et al. Analysis of the fine specificity of rat, mouse and human TAP peptide transporters. Eur J Immunol 1995; 25: 1133-1136.
10. Momburg F, Armandola EA, Post M, Hämmerling GJ. Residues in TAP2 peptide transporters controlling substrate specificity. J Immunol 1996; 156: 1756-63.
11. Armandola EA, Momburg F, Nijenhuis M, Bulbuc N, Früh K, Hämmerling GJ. A point mutation in the human transporter associated with antigen processing (TAP2) alters the peptide transport specificity. Eur J Immunol 1996; 26: 1748-1755.
12. Barron KS, Reveille JD, Carrington M, Mann D, Robinson M. Susceptibility to Reiter's Syndrome is associated with alleles of TAP genes. Arthritis Rheum 1995; 38: 684-689.
13. Yan G, Shi L, Fu Y et al. Screening of the TAP1 gene by denaturing gradient gel electrophoresis in insulin-dependent diabetes mellitus: detection and comparison of new polymorphisms between patients and controls. Tissue Antigens 1997; 50: 576-585.
14. Braud V, Chevrier D, Cesbron A et al. Susceptibility to alloimmunization to platelet HPA-1a antigen involves TAP1 polymorphism. Hum Immunol 1994; 41: 141-145.
15. Tang J, Allen S, Karita E, Musonda R, Kaslow RA. New TAP2 polymorphisms in Africans. Tissue Antigens 1998; 51: 556-562.
16. Powis SH, Deverson EV, Coadwell WJ et al. Effect of polymorphism of a MHC-linked transporter on the peptides assembled in a class I molecule. Nature 1992; 357: 211-215.
17. Daniel S, Caillat-Zucman S, Hammer J, Bach JF, van Endert PM. Absence of functional relevance of human transporter associated with antigen processing polymorphism for peptide selection. J Immunol 1997; 159: 2350-2357.
18. Obst R, Armandola EA, Nijenhuis M, Momburg F, Hammerling GJ. TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur J Immunol 1995; 25: 2170-2176.
19. Quadri SA, Singal DP. Peptide transport in human lymphoblastoid and tumor cells: effect of transporter associated with antigen presentation (TAP) polymorphism. Immunol Let 1998; 61: 25-31.
20. Nijenhuis M, Schmitt S, Armandola EA, Obst R, Brunner J, Hammerling GJ. Identification of a contact region for peptide on the TAP1 chain of the transporter associated with antigen processing. J Immunol 1996; 156: 2186-2195.
21. Nijenhuis M, Hammerling GJ. Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site. J Immunol 1996; 157: 5467-5477.
22. Kaslow RA, Carrington M, Apple R et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996; 2: 405-411.
23. Detels R, Mann D, Carringtyon M et al. Persistently seronegative men from whom HIV-1 has been isolated are genetically and immunologically distinct. Immunol Let 1996; 51: 29-33.
24. Wordsworth BP, Pile KD, Gibson K, Burney RO, Mockridge I, Powis SH. Analysis of the MHC-encoded transporters TAP1 and TAP2 in rheumatoid arthritis: linkage with DR4 accounts for the association with a minor TAP2 allele. Tissue Antigens 1993; 42: 153-155.
25. Ploski R, Undlien DG, Vinje O, Forre O, Thorsby E, Ronningen KS. Polymorphism of human major histocompatibility complex-encoded transporter associated with antigen processing (TAP) genes and susceptibility to juvenile rheumatoid arthritis. Hum Immunol 1994; 38: 54-60.
26. Vandevyver C, Stinissen P, Cassiman J, Raus J. TAP1 and TAP2 transporter gene polymorphisms in multiple sclerosis: no evidence for disease association with TAP. J Neuroimmunol 1994; 54: 35-40.
27. Bell R, Ramachandran S. The relationship of TAP1 and TAP2 dimorphisms to multiple sclerosis susceptibility. J Neuroimmunol 1995, 59: 201-204.
28. Spurkland A, Knutsen I, Undlien D, Vartdal F. No association of multiple sclerosis to alleles at the TAP2 locus. Hum Immunol 1994; 39: 299-301.
29. Moins-Teisserenc H, Semana G, Alizadeh M et al. TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosis. Hum Immunol 1995; 42: 195-202.
30. Middleton D, Megaw G, Cullen C, Hawkins S, Darke C, Savage D. TAP1 and TAP2 polymorphism in multiple sclerosis patients. Hum Immunol 1994; 40: 131-134.
31. Ronningen K, Undlien D, Ploski R et al. Linkage disequilibrium between TAP2 variants and HLA class II alleles: no primary association between TAP2 variants and insulin-dependent diabetes mellitus. J Immunol 1993; 23: 1050-1056.
32. Liandong M, Penfornis A, Xaiolin W et al. Evaluation of TAP1 polymorphisms with Insulin dependent diabetes mellitus in Finnish diabetic patients. Hum Immunol 1997; 53: 159-166.
33. Caillat-Zucman S, Bertin E, Timsit J, Boitard C, Assan R, Bach J. Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur J Immunol 1993; 23: 1784-1788.
34. Maungendre D, Alizadeh M, Gauthier A et al. Genetic heterogeneity between type 1a and type 1b insulin-dependent diabetes mellitus: HLA Class II and TAP gene analysis. Tissue Antigens 1996; 48: 540-548.
35. Caillat-Zuckman S, Daniel S, Djilali-Saiah I et al. Family study of linkage disequilibrium between TAP2 transporter and HLA Class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus. Hum Immunol 1995; 44: 80-87.
36. Esposito L, Lampasona V, Bosi E, Poli F, Ferrari M, Bonifacio E. HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus. Diabetologia 1995; 38: 968-974.
37. Martinez-Laso J, Martin-Villa JM, Alvarez M, Martinez N, Lledo G, Arnaiz A. Susceptibility to insulin-dependent diabetes mellitus and short cytoplasmic ATP-binding domain TAP2*01 alleles. Tissue Antigens 1994; 44: 184-188.
38. Cucca F, Congia M, Trowsdale J, Powis SH. Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: no association in a population with a high disease incidence. Tissue Antigens 1994; 44: 234-240.
39. Hjelmström P, Giscombe R, Lefvert AK et al. TAP polymorphisms in Swedish myasthenia gravis patients. Tissue Antigens 1997; 49: 176-179.
40. Davies EJ, Donn RP, Hillarby MC, Grennan DM, Ollier WER. Polymorphisms of the TAP2 transporter gene in systemic lupus erythematosus. Ann Rheum Dis 1994; 53: 61-63.
41. Öcal L, Russell K, Beynon H, Cruckshank K et al. Genetic analysis of TAP2 in systemic lupus erythematosus patients from two ethnic groups. Br J Rheumatol 1996; 35: 529-533.
42. Savage DA, Ng SC, Howe HS et al. HLA and TAP associations in Chinese systemic lupus erythematosus patients. Tissue Antigens 1995; 46: 213-216.
43. Rajalingam R, Singal DP, Mehra NK. Transporter associated with antigen-processing (TAP) genes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis. Tissue Antigens 1997; 49: 168-172.
44. Laud PR, Loflin PT, Jeevan A, Lawlor DA. Transporter associated with antigen-processing-1 (TAP1) alleles in Gorilla gorilla: diversification of the locus postspeciation. Hum Immunol 1996; 50: 91-102.
45. Cadavid LF, Watkins DI. Heirs of the jaguar and the anaconda: HLA, conquest and disease in the indigenous populations of the Americas. Tissue Antigens 1997; 50: 209-218.
46. Cano P, Baxter-Lowe LA. Novel human TAP2*103 allele shows further polymorphism in the ATP-binding domain. Tissue Antigens 1995; 45: 139-142.
47. Pattanakitsakul S, Takeuchi F, Nabeta H et al. A novel TAP2 gene RFLP observed in a Japanese. Tissue Antigens 1996; 47: 353-355.
48. Terrazas BE, Perez-Ruiz ML. Pueblos Indígenas de México. Seris. ed. Instituto Nacional Indigenista, Mexico D.F., 1993.
49. Serrano C. Mestizaje e historia de la población en México. In: Municio AM, García Barreno P (eds). Polimorfismo Génico (HLA) en poblaciones hispanoamericanas. Real Academia de Ciencias exactas, Físicas y naturales de Españ a. Madrid, 1996, pp 173-193.
50. Gorodezky C, Alaez C, Vázquez-García MN et al. The genetic structure of Mexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems and microsatellites. Hum Immunol 2001; 62: 979-991.
51. Djilali-Saiah I, Benini V, Daniel S, Assan R, Bach JF, Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens 1996; 48: 87-92.
52. Hohler T, Weinmann A, Scheneider PM et al. TAP polymorphisms in juvenile onset psoriasis and psoriatic arthritis. Hum Immunol 1996; 51: 49-54.
53. González-Escribano MF, Morales J, Garcia-Lozano JR et al. TAP polymorphism in patients with Behçet's disease. Ann Rheum Dis 1995; 54: 386-388.
54. Jackson DG, Capra JD. TAP2 association with insulin-dependent diabetes mellitus is secondary to HLA-DQB1. Hum Immunol 1995; 43: 57-65.
55. Ismail A, Bousaffara R, Kaziz J et al. Polymorphism in transporter antigen peptide gene (TAP1) associated with atopy in Tunisians. J Aller Clin Immunol 1997; 99: 216-223.
56. Kuwata S, Yanagisawa M, Saeki H et al. Polymorphisms of transporter associated with antigen processing genes in atopic dermatitis. J Aller Clin Immunol 1994; 94: 565-574.
57. Kumagai S, Kanagawa S, Morinobu A et al. Association of a new allele of the TAP2 gene TAP2*Bky2 (Val 577), with susceptibility to Sjögren's syndrome. Arthr Rheum 1997; 40: 1685-1692.
58. Bianchine PJ, Russo TA. The role of epidemic infectious disease in the discovery of America. In: Settipane GA (ed). Columbus and the New World: Medical implication. Providence: Oceanside Publications, Rhode Island, 1995, pp 19-24.
59. Gorodezky C. Genetic difference between Europeans and indians: tissue and blood types. Allergy Proc 1992; 13: 243-250.
60. Parham P, Arnet KL, Adams EJ et al. Episodic evolution and turnover of HLA-B in the indigenous human populations of the Americas. Tissue Antigens 1997; 50: 219-232.
61. Fernández-Viña MA, Lázaro AM, Marcos CY et al. Dissimilar evolution of B-locus versus A-locus and class II loci of the HLA region in South American Indian tribes. Tissue Antigens 1997; 50: 233-250.
62. Cullen M, Noble J, Erlich H et al. Characterization of recombination in the HLA class II region. Am J Hum Genet 1997; 60: 397-407.
63. Tang J, Freedman D, Allen S et al. TAP1 Polymorphisms in several human ethnic groups: Characteristics, evolution, and genotyping strategies. Hum Immunol, 2001; 62: 256-268.
64. Petzl-Erler ML, Luz R, Santos-Sotomaior V. The HLA polymorphism of two distinctive South-American Indian tribes: the Kaingang and the Guarani. Tissue Antigens 1993; 41: 227-237.
65. Raghavan M. Immunodeficiency due to defective antigen processing: the molecular basis for type 1 bare lymphocyte syndrome. J Clin Invest 1999; 103: 595-596.
66. Infante E, Olivo A, Alaez C et al. Molecular analysis of HLA class I alleles in the Mexican Seri Indians: implications for their origin. Tissue Antigens 1999; 54: 35-42.
67. Petzl-Erler ML, Gorodezky C, Layrisse Z et al. Anthropology report for Region Latin-America: Amerindian and admixed populations. Anthropology: contribution of HLA. In: Charron D (ed). HLA. Genetic Diversity of HLA: functional and medical implications. EDK Medical and Scientific International Publisher: Paris, 1997, pp 337-344.
68. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a laboratory manual 2nd edn. Cold Spring Harbor Laboratory Press: New York, 1989, Appendix E.
69. Mendelian populations. In: Hartl DL (ed). Principles of Population Genetics. Sinauer Associates: Massachusetts, 1980, pp 93-102.
70. Mattiuz PL, Ihde D, Piazza A, Cepellini R, Bodmer WF. New approaches to the population genetic segregation analysis of the HLA system. In: Terasaki PI (ed). Histocompatibility Testing. Munksgaard: Copenhagen, 1970, pp 193-205.